Cargando…
1986. Multicenter evaluation of Staphylococcus aureus prosthetic valve infective endocarditis with and without gentamicin treatment: Is it time to revisit?
BACKGROUND: Staphylococcus aureus prosthetic valve infective endocarditis (SA-PVIE) is associated with high mortality. Gentamicin (GEN) with anti-staphylococcal antibiotics and rifampin are guideline recommendations for SA-PVIE extrapolated from in vitro data. GEN can lead to acute kidney injury (AK...
Autores principales: | Pham, Tho H, Molina, Kyle C, Erdman, Grace, Miller, Matthew A, Huang, Vanthida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752687/ http://dx.doi.org/10.1093/ofid/ofac492.1611 |
Ejemplares similares
-
Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus
por: Gilbey, Timothy, et al.
Publicado: (2019) -
Rapid progression of Staphylococcus lugdunensis mechanical prosthetic valve endocarditis
por: Naji, Darwish I, et al.
Publicado: (2015) -
“A contemporary description of staphylococcus aureus prosthetic valve endocarditis. Differences according to the time elapsed from surgery”
por: Sáez, Carmen, et al.
Publicado: (2019) -
Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus
In Vitro and In Vivo
por: Kaul, Grace, et al.
Publicado: (2023) -
Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis
por: Ryder, Jonathan H, et al.
Publicado: (2022)